INSIGHTS ON DRUG DEVELOPMENT

• Lonza Advanced Synthesis Capabilities Update February 2026: AI Drug Development

  Learn how our scientists accurately predict and identify the most stable cocrystal forms by leveraging advanced machine learning models, enhancing efficiency and reducing development risks.

• Creative Chromatography Solutions For Complex Small Molecules

  Chromatographic modeling enables smarter purification. Discover how digital tools, fraction mapping, and expert execution can improve yield for the most challenging small-molecule separations.

• Suitability Testing For IVT mRNA Analysis

  Automated capillary electrophoresis provides robust, precise analysis of IVT mRNA integrity, concentration, and size, demonstrating excellent method precision.

• Managing Endotoxins - Detect, Prevent, Remove

  Explore the risks of endotoxin contamination in drug manufacturing and discover sustainable, animal-free detection methods to ensure pharmaceutical safety and regulatory compliance.

• Precision By Design: Drug Innovation Through Structure-Based Drug Design (SBDD)

  5/6/2026

  Leverage structure-based drug design to gain deeper molecular insights, prioritize high-potential candidates, and accelerate your path from discovery to clinic.

• Lentiviral Vector Upstream Process

  12/12/2025

  Scalable lentiviral vector production is moving beyond adherent systems. Learn how streamlined workflows enable linear scale-up in stirred-tank bioreactors for cost-effective gene therapy manufacturing.

• MAPK Signaling Pathway

  4/7/2025

  Mitogen-activated protein kinase cascades regulate key cellular processes like proliferation, differentiation, and apoptosis. Explore how these pathways maintain cellular homeostasis and contribute to disease development.

• Lightning-Link^® Conjugation Kits: Consistent Performance On A Broad Scale

  9/26/2024

  Learn about labeling technology offering a transformative solution through direct antibody labeling without the need for post-conjugation purification, thereby mitigating antibody loss and ensuring reproducible results.

• Column Selection For RPLC-UV Impurity Analysis

  7/17/2025

  Explore the performance of four column chemistries for RPLC-UV impurity analysis of liraglutide and semaglutide, which offers practical guidance for method development in peptide-based therapeutics.